Early alterations of myocardial blood flow reserve in heart transplant recipients with angiographically normal coronary arteries. 2000

N Preumont, and G Berkenboom, and J Vachiery, and J Jansens, and M Antoine, and D Wikler, and P Damhaut, and S Degré, and A Lenaers, and S Goldman
Department of Cardiology, Erasme Hospital, Free University of Brussels, Brussels, Belgium.

BACKGROUND The evaluation of the coronary reserve provides valuable information on the status of coronary vessels. Therefore, we studied with positron emission tomography (PET) and 13N-ammonia the myocardial blood flow (MBF) reserve in heart transplant recipients free of allograft rejection and with angiographically normal coronary arteries early after heart transplantation (HTx). The MBF reserve was calculated as the ratio between MBF after dipyridamole injection and basal MBF normalized for the rate-pressure product. METHODS Patients were studied within 3 months (group A, n = 12) or more than 9 months (group B, n = 12) after HTx. Five patients have been studied both during the early and late period after HTx. Results were compared to those obtained in 7 normal volunteers (NL). RESULTS Group A recipients had a significantly lower dipyridamole MBF (in ml/min/100 gr of tissue) than that of group B recipients (142+/-34 vs 195+/-59, p<0.05). This resulted in a significant decrease in MBF reserve early after HTx (group A: 1.82+/- 0.33) and a restoration to normal values thereafter (group B: 2.52+/- 0.53 vs NL: 2.62+/-0.51, p = ns). Separate analysis of 5 patients studied twice is consistent with these results. CONCLUSIONS This study shows that in heart transplant recipients free of allograft rejection and with normal coronary angiography, MBF reserve is impaired early after HTx. Restoration within one year suggests that this abnormality does not represent an early stage of cardiac allograft vasculopathy.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011184 Postoperative Period The period following a surgical operation. Period, Postoperative,Periods, Postoperative,Postoperative Periods
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D012146 Rest Freedom from activity. Rests
D001783 Blood Flow Velocity A value equal to the total volume flow divided by the cross-sectional area of the vascular bed. Blood Flow Velocities,Flow Velocities, Blood,Flow Velocity, Blood,Velocities, Blood Flow,Velocity, Blood Flow
D003326 Coronary Circulation The circulation of blood through the CORONARY VESSELS of the HEART. Circulation, Coronary
D003331 Coronary Vessels The veins and arteries of the HEART. Coronary Arteries,Sinus Node Artery,Coronary Veins,Arteries, Coronary,Arteries, Sinus Node,Artery, Coronary,Artery, Sinus Node,Coronary Artery,Coronary Vein,Coronary Vessel,Sinus Node Arteries,Vein, Coronary,Veins, Coronary,Vessel, Coronary,Vessels, Coronary
D004176 Dipyridamole A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752) Antistenocardin,Apo-Dipyridamole,Cerebrovase,Cléridium,Curantil,Curantyl,Dipyramidole,Kurantil,Miosen,Novo-Dipiradol,Persantin,Persantine,Apo Dipyridamole,Novo Dipiradol

Related Publications

N Preumont, and G Berkenboom, and J Vachiery, and J Jansens, and M Antoine, and D Wikler, and P Damhaut, and S Degré, and A Lenaers, and S Goldman
November 1999, Transplantation,
N Preumont, and G Berkenboom, and J Vachiery, and J Jansens, and M Antoine, and D Wikler, and P Damhaut, and S Degré, and A Lenaers, and S Goldman
April 1983, The American journal of cardiology,
N Preumont, and G Berkenboom, and J Vachiery, and J Jansens, and M Antoine, and D Wikler, and P Damhaut, and S Degré, and A Lenaers, and S Goldman
August 1998, Transplantation proceedings,
N Preumont, and G Berkenboom, and J Vachiery, and J Jansens, and M Antoine, and D Wikler, and P Damhaut, and S Degré, and A Lenaers, and S Goldman
January 2008, Cardiology,
N Preumont, and G Berkenboom, and J Vachiery, and J Jansens, and M Antoine, and D Wikler, and P Damhaut, and S Degré, and A Lenaers, and S Goldman
January 1987, Catheterization and cardiovascular diagnosis,
N Preumont, and G Berkenboom, and J Vachiery, and J Jansens, and M Antoine, and D Wikler, and P Damhaut, and S Degré, and A Lenaers, and S Goldman
February 1994, Archives of internal medicine,
N Preumont, and G Berkenboom, and J Vachiery, and J Jansens, and M Antoine, and D Wikler, and P Damhaut, and S Degré, and A Lenaers, and S Goldman
October 1980, Annals of the Academy of Medicine, Singapore,
N Preumont, and G Berkenboom, and J Vachiery, and J Jansens, and M Antoine, and D Wikler, and P Damhaut, and S Degré, and A Lenaers, and S Goldman
October 2002, Journal of the Royal Society of Medicine,
N Preumont, and G Berkenboom, and J Vachiery, and J Jansens, and M Antoine, and D Wikler, and P Damhaut, and S Degré, and A Lenaers, and S Goldman
November 2011, Atherosclerosis,
N Preumont, and G Berkenboom, and J Vachiery, and J Jansens, and M Antoine, and D Wikler, and P Damhaut, and S Degré, and A Lenaers, and S Goldman
January 1995, Chest,
Copied contents to your clipboard!